Innate and adaptive immunity during SARS-CoV-2 infection: biomolecular cellular markers and mechanisms
The coronavirus 2019 (COVID-19) pandemic was caused by a positive sense single-
stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[HTML][HTML] Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19
The expansion of myeloid-derived suppressor cells (MDSCs), known as heterogeneous
population of immature myeloid cells, is enhanced during several pathological conditions …
population of immature myeloid cells, is enhanced during several pathological conditions …
[HTML][HTML] Coronavirus disease–2019 and the intestinal tract: An overview
GGF Alberca, RL Solis-Castro… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can progress to a
severe respiratory and systemic disease named coronavirus disease–2019 (COVID-19) …
severe respiratory and systemic disease named coronavirus disease–2019 (COVID-19) …
COVID-19 disease course in former smokers, smokers and COPD patients
RW Alberca, JC Lima, EA Oliveira… - Frontiers in …, 2021 - frontiersin.org
The severe respiratory and systemic disease named coronavirus disease-2019 (COVID-19)
is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently …
is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently …
Long-term effects of COVID-19 in diabetic and non-diabetic patients
The literature presents several reports of the impact of glycemic control and diabetes in the
inflammatory and coagulatory response during coronavirus disease 2019 (COVID-19) …
inflammatory and coagulatory response during coronavirus disease 2019 (COVID-19) …
Clinical characteristics and survival analysis in frequent alcohol consumers with COVID-19
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can generate a
systemic disease named coronavirus disease–2019 (COVID-19). Currently, the COVID-19 …
systemic disease named coronavirus disease–2019 (COVID-19). Currently, the COVID-19 …
Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19
S Martínez-Diz, F Marín-Benesiu… - Frontiers in …, 2023 - frontiersin.org
Background Approximately 13.8% and 6.1% of coronavirus disease 2019 (COVID-19)
patients require hospitalization and sometimes intensive care unit (ICU) admission …
patients require hospitalization and sometimes intensive care unit (ICU) admission …
Platelet-based biomarkers for diagnosis and prognosis in COVID-19 patients
Coronavirus disease 2019 (COVID-19) caused millions of deaths worldwide. COVID-19's
clinical manifestations range from no symptoms to a severe acute respiratory syndrome …
clinical manifestations range from no symptoms to a severe acute respiratory syndrome …
Immune response to COVID-19
RW Alberca - Fighting the COVID-19 Pandemic, 2021 - books.google.com
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) invades the host's
cells via the angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine …
cells via the angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine …
Cellular and Humoral Immunity and Infection Responses to SARS-CoV-2: Immune Biomolecular Mechanisms by Case Study within SARS-CoV-2 Pathogenesis and …
Abstract The coronavirus 2019 (COVID-19) pandemic was caused by a positive sense
single-stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
single-stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV …